Loading clinical trials...
Loading clinical trials...
Efficacy of Adductor Canal Block for Anterior Cruciate Ligament Surgery: A Prospective Double Blinded Randomized Controlled Trial
The goal of this study is to objectify the postoperative pain level, the use of opiates and postoperative nausea and vomiting after adding the adductor canal block to the standard pain regiment after anterior cruciate ligament surgery
Patients scheduled for anterior cruciate ligament surgery will be randomized in an intervention and control group following informed consent. Before surgery, patients will receive an adductor canal bock with Levobupivacaine (intervention group) or 0.9% saline (control group). Following surgery, pain intensity, analgesic consumption and pain satisfaction will be recorded bij patients in a diary for 48 hours.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
St. Antonius Ziekenhuis
Nieuwegein, Netherlands
Start Date
August 1, 2022
Primary Completion Date
August 1, 2023
Completion Date
August 1, 2023
Last Updated
September 13, 2023
34
ACTUAL participants
Adductor canal block
PROCEDURE
Levobupivacaine
DRUG
Placebo
DRUG
Lead Sponsor
St. Antonius Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions